Tags

Type your tag names separated by a space and hit enter

Therapeutic Particularities with Depot Medications in Schizophrenia.
Curr Health Sci J. 2018 Jul-Sep; 44(3):322-325.CH

Abstract

Schizophrenia is a neurodegenerative disease with personality degradation, changes in behavior, cognition, affective disorder and reduced socio-professional insertion. Early diagnosis is necessary and maintenance is ensured by antipsychotic treatment and for non-compliant patients there is an alternative to depot medication that greatly improves therapeutic adherence. The study presents the case of a 43-year-old patient diagnosed with paranoid schizophrenia using the Diagnostic and Statistical Manual of Mental Disorders V-TR criteria that showed a favorable evolution under depot treatment.

Authors+Show Affiliations

Department of Psychiatry, Clinical Hospital of Neuropsychiatry Craiova.Department of Psychiatry, Clinical Hospital of Neuropsychiatry Craiova.Department of Psychiatry, Clinical Hospital of Neuropsychiatry Craiova.Department of Psychiatry, Clinical Hospital of Neuropsychiatry Craiova.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

30647956

Citation

Sârbu, C, et al. "Therapeutic Particularities With Depot Medications in Schizophrenia." Current Health Sciences Journal, vol. 44, no. 3, 2018, pp. 322-325.
Sârbu C, Bădescu GȘ, Hromei AE, et al. Therapeutic Particularities with Depot Medications in Schizophrenia. Curr Health Sci J. 2018;44(3):322-325.
Sârbu, C., Bădescu, G. Ș., Hromei, A. E., & Stănia, I. D. (2018). Therapeutic Particularities with Depot Medications in Schizophrenia. Current Health Sciences Journal, 44(3), 322-325. https://doi.org/10.12865/CHSJ.44.03.19
Sârbu C, et al. Therapeutic Particularities With Depot Medications in Schizophrenia. Curr Health Sci J. 2018 Jul-Sep;44(3):322-325. PubMed PMID: 30647956.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Therapeutic Particularities with Depot Medications in Schizophrenia. AU - Sârbu,C, AU - Bădescu,G Ș, AU - Hromei,A E, AU - Stănia,I D, Y1 - 2018/07/15/ PY - 2018/06/22/received PY - 2018/09/12/accepted PY - 2019/1/17/entrez PY - 2019/1/17/pubmed PY - 2019/1/17/medline KW - Schizophrenia KW - depot treatment KW - psychodiagnosis SP - 322 EP - 325 JF - Current health sciences journal JO - Curr Health Sci J VL - 44 IS - 3 N2 - Schizophrenia is a neurodegenerative disease with personality degradation, changes in behavior, cognition, affective disorder and reduced socio-professional insertion. Early diagnosis is necessary and maintenance is ensured by antipsychotic treatment and for non-compliant patients there is an alternative to depot medication that greatly improves therapeutic adherence. The study presents the case of a 43-year-old patient diagnosed with paranoid schizophrenia using the Diagnostic and Statistical Manual of Mental Disorders V-TR criteria that showed a favorable evolution under depot treatment. SN - 2067-0656 UR - https://www.unboundmedicine.com/medline/citation/30647956/Therapeutic_Particularities_with_Depot_Medications_in_Schizophrenia L2 - https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/30647956/ DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.